{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:08:01Z","timestamp":1785928081376,"version":"3.56.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["Project Grant- 391676"],"award-info":[{"award-number":["Project Grant- 391676"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-154294"],"award-info":[{"award-number":["FDN-154294"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PTT-190383"],"award-info":[{"award-number":["PTT-190383"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100014405","name":"Centre for Addiction and Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010523","name":"Centre for Addiction and Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010523","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Canadian Foundation for Innovation\/Ontario Research Funds","award":["41713"],"award-info":[{"award-number":["41713"]}]},{"name":"National Institute of Health of United States National Institute on Alcohol Abuse and Alcoholism","award":["P50 AA026117"],"award-info":[{"award-number":["P50 AA026117"]}]},{"name":"National Institute of Health of United States National Institute on Alcohol Abuse and Alcoholism","award":["U01 AA014091"],"award-info":[{"award-number":["U01 AA014091"]}]},{"DOI":"10.13039\/100000026","name":"HHS | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA054694"],"award-info":[{"award-number":["R01 DA054694"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"HHS | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA048490"],"award-info":[{"award-number":["R01 DA048490"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"HHS | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32 AA007565"],"award-info":[{"award-number":["T32 AA007565"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The dopamine transporter is essential for dopamine homeostasis maintenance. Therefore, single amino acid changes in its gene can be sufficient to induce disease, such as dopamine transporter deficiency syndrome (DTDS). DTDS-associated variants may lead to DAT protein misfolding, retention in the endoplasmic reticulum, and reduced DAT surface expression. In turn, proper dopaminergic regulation is lost. Current treatments for DTDS are largely ineffective, necessitating better options. We developed a novel mouse model of DTDS harboring the A313V knock-in DAT variant, a proxy for the human A314V variant. The A313V mice are hyperactive, have decreased striatal tissue content of dopamine and increases in its metabolite HVA, and impaired dopamine uptake. FDA approved compounds alpha-methyl-para-tyrosine and amphetamine ameliorate the observed hyperactivity. Moreover, alpha-methyl-para-tyrosine may be a disease-modifying treatment by addressing the hyperdopaminergic tone underlying this hyperactivity. Noribogaine, a pharmacological chaperone for DAT, is unable to rescue DAT expression. These findings demonstrate that the A313V knock-in DAT variant mice recapitulate several defining phenotypes seen in patients with DTDS, and provide evidence for two novel treatments for the disease.<\/jats:p>","DOI":"10.1038\/s44321-026-00381-0","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T15:01:18Z","timestamp":1771254078000},"page":"1054-1090","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Alpha-methyl-para-tyrosine and amphetamine ameliorate hyperactivity in a novel mouse model of dopamine transporter deficiency syndrome"],"prefix":"10.1038","volume":"18","author":[{"given":"Emma E","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2806-2057","authenticated-orcid":false,"given":"Ameneh","family":"Rezayof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conner","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin Q","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3721-3213","authenticated-orcid":false,"given":"Pieter","family":"Beerepoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marija","family":"Milenkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Novalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aled","family":"Blundell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana V","family":"Lipina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2940-6390","authenticated-orcid":false,"given":"Raveen","family":"Christian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S B","family":"Finnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landon J","family":"Edgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel F","family":"Tyndale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Watkins-Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy J","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-7576","authenticated-orcid":false,"given":"Sara R","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4712-2091","authenticated-orcid":false,"given":"Ali","family":"Salahpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"381_CR1","doi-asserted-by":"crossref","unstructured":"Aguilar JI, Cheng MH, Font J, Schwartz AC, Ledwitch K, Duran A, Mabry SJ, Belovich AN, Zhu Y, Carter AM et al (2021) Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia. eLife 10:e68039","DOI":"10.7554\/eLife.68039"},{"issue":"1","key":"381_CR2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1176\/jnp.2007.19.1.65","volume":"19","author":"R Ankenman","year":"2007","unstructured":"Ankenman R, Salvatore MF (2007b) Low dose alpha-methyl-para-tyrosine (AMPT) in the treatment of dystonia and dyskinesia. J Neuropsychiatry Clin Neurosci 19(1):65\u201369","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"47","key":"381_CR3","doi-asserted-by":"publisher","first-page":"19250","DOI":"10.1074\/jbc.M117.797092","volume":"292","author":"HMM Asjad","year":"2017","unstructured":"Asjad HMM, Kasture A, El-Kasaby A, Sackel M, Hummel T, Freissmuth M, Sucic S (2017) Pharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile\/juvenile Parkinsonism. J Biol Chem 292(47):19250\u201319265","journal-title":"J Biol Chem"},{"issue":"10","key":"381_CR4","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1212\/01.WNL.0000126440.16612.51","volume":"62","author":"BE Assmann","year":"2004","unstructured":"Assmann BE, Robinson RO, Surtees RAH, Br\u00e4utigam C, Heales SJR, Wevers RA, Zschocke J, Hyland K, Sharma R, Hoffmann GF (2004) Infantile parkinsonism-dystonia and elevated dopamine metabolites in CSF. Neurology 62(10):1872\u20131874","journal-title":"Neurology"},{"issue":"23","key":"381_CR5","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1007\/s00018-021-03994-5","volume":"78","author":"N Baatallah","year":"2021","unstructured":"Baatallah N, Elbahnsi A, Mornon J-P, Chevalier B, Pranke I, Servel N, Zelli R, D\u00e9cout J-L, Edelman A, Sermet-Gaudelus I, Callebaut I, Hinzpeter A (2021) Pharmacological chaperones improve intra-domain stability and inter-domain assembly via distinct binding sites to rescue misfolded CFTR. Cell Mol Life Sci: CMLS 78(23):7813\u20137829","journal-title":"Cell Mol Life Sci: CMLS"},{"issue":"2","key":"381_CR6","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1017\/cjn.2020.144","volume":"48","author":"M Baga","year":"2021","unstructured":"Baga M, Spagnoli C, Soliani L, Salerno GG, Rizzi S, Frattini D, Pisani F, Fusco C (2021) Early-onset dopamine transporter deficiency syndrome: long-term follow-up. Can J Neurol Sci 48(2):285\u2013286","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"381_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1523\/JNEUROSCI.0744-20.2020","volume":"41","author":"TR Bagalkot","year":"2021","unstructured":"Bagalkot TR, Block ER, Bucchin K, Balcita-Pedicino JJ, Calderon M, Sesack SR, Sorkin A (2021) Dopamine transporter localization in medial forebrain bundle axons indicates its long-range transport primarily by membrane diffusion with a limited contribution of vesicular traffic on retromer-positive compartments. J Neurosci 41(2):234","journal-title":"J Neurosci"},{"issue":"5","key":"381_CR8","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/ana.21947","volume":"67","author":"JA Beeler","year":"2010","unstructured":"Beeler JA, Cao ZFH, Kheirbek MA, Ding Y, Koranda J, Murakami M, Kang UJ, Zhuang X (2010) Dopamine-dependent motor learning: insight into levodopa\u2019s long-duration response. Ann Neurol 67(5):639\u2013647","journal-title":"Ann Neurol"},{"issue":"42","key":"381_CR9","doi-asserted-by":"publisher","first-page":"22053","DOI":"10.1074\/jbc.M116.749119","volume":"291","author":"P Beerepoot","year":"2016","unstructured":"Beerepoot P, Lam VM, Salahpour A (2016) Pharmacological chaperones of the dopamine transporter rescue dopamine transporter deficiency syndrome mutations in heterologous cells. J Biol Chem 291(42):22053\u201322062","journal-title":"J Biol Chem"},{"issue":"8","key":"381_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1001084","volume":"6","author":"A Benedetto","year":"2010","unstructured":"Benedetto A, Au C, Avila DS, Milatovic D, Aschner M (2010) Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet 6(8):e1001084","journal-title":"PLoS Genet"},{"issue":"2","key":"381_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1021\/acsptsci.0c00102","volume":"4","author":"S Bhat","year":"2021","unstructured":"Bhat S, Guthrie DA, Kasture A, El-Kasaby A, Cao J, Bonifazi A, Ku T, Giancola JB, Hummel T, Freissmuth et al (2021) Tropane-based ibogaine analog rescues folding-deficient serotonin and dopamine transporters. ACS Pharmacol Transl Sci 4(2):503\u2013516","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"381_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0896-6273(00)80353-0","volume":"19","author":"R Boss\u00e9","year":"1997","unstructured":"Boss\u00e9 R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, Wetsel WC, Missale C, Caron MG (1997) Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron 19(1):127\u2013138","journal-title":"Neuron"},{"issue":"2","key":"381_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.2165\/00003495-198121020-00001","volume":"21","author":"RN Brogden","year":"1981","unstructured":"Brogden RN, Heel RC, Speight TM, Avery GS (1981) Alpha-methyl-p-tyrosine: a review of its pharmacology and clinical use. Drugs 21(2):81\u201389","journal-title":"Drugs"},{"issue":"1","key":"381_CR15","first-page":"1","volume":"7","author":"M Bu","year":"2021","unstructured":"Bu M, Farrer MJ, Khoshbouei H (2021) Dynamic control of the dopamine transporter in neurotransmission and homeostasis. NPJ Parkinson\u2019s Dis 7(1):1\u201311","journal-title":"NPJ Parkinson\u2019s Dis"},{"issue":"2","key":"381_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1523\/JNEUROSCI.3602-07.2008","volume":"28","author":"L Chen","year":"2008","unstructured":"Chen L, Ding Y, Cagniard B, Laar ADV, Mortimer A, Chi W, Hastings TG, Kang UJ, Zhuang X (2008) Unregulated cytosolic dopamine causes neurodegeneration associated with oxidative stress in mice. J Neurosci 28(2):425\u2013433","journal-title":"J Neurosci"},{"issue":"1\u20133","key":"381_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0014-2999(00)00563-X","volume":"405","author":"N Chen","year":"2000","unstructured":"Chen N, Reith ME (2000) Structure and function of the dopamine transporter. Eur J Pharmacol 405(1\u20133):329\u2013339","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"381_CR18","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"H-C Cheng","year":"2010","unstructured":"Cheng H-C, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67(6):715\u2013725","journal-title":"Ann Neurol"},{"issue":"1","key":"381_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1","volume":"409","author":"BJ Ciliax","year":"1999","unstructured":"Ciliax BJ, Drash GW, Staley JK, Haber S, Mobley CJ, Miller GW, Mufson EJ, Mash DC, Levey AI (1999) Immunocytochemical localization of the dopamine transporter in human brain. J Comp Neurol 409(1):38\u201356","journal-title":"J Comp Neurol"},{"issue":"3 Pt 1","key":"381_CR20","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1523\/JNEUROSCI.15-03-01714.1995","volume":"15","author":"BJ Ciliax","year":"1995","unstructured":"Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI (1995) The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 15(3 Pt 1):1714\u20131723","journal-title":"J Neurosci"},{"issue":"19","key":"381_CR21","doi-asserted-by":"publisher","first-page":"11035","DOI":"10.1073\/pnas.1831768100","volume":"100","author":"M Cyr","year":"2003","unstructured":"Cyr M, Beaulieu J-M, Laakso A, Sotnikova TD, Yao W-D, Bohn LM, Gainetdinov RR, Caron MG (2003) Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proc Natl Acad Sci USA 100(19):11035\u201311040","journal-title":"Proc Natl Acad Sci USA"},{"key":"381_CR22","first-page":"e2609","volume":"75","author":"RMJ Deacon","year":"2013","unstructured":"Deacon RMJ (2013) Measuring motor coordination in mice. JoVE 75:e2609","journal-title":"JoVE"},{"issue":"8","key":"381_CR23","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1172\/JCI127411","volume":"129","author":"GE DiCarlo","year":"2019","unstructured":"DiCarlo GE, Aguilar JI, Matthies HJ, Harrison FE, Bundschuh KE, West A, Hashemi P, Herborg F, Rickhag M, Chen H et al (2019) Autism-linked dopamine transporter mutation alters striatal dopamine neurotransmission and dopamine-dependent behaviors. J Clin Investig 129(8):3407\u20133419","journal-title":"J Clin Investig"},{"key":"381_CR24","doi-asserted-by":"publisher","unstructured":"Drossos C, Hunter SJ (2011) Juvenile Parkinson\u2019s disease. In Kreutzer JS, DeLuca J, Caplan B (eds), Encyclopedia of clinical neuropsychology. Springer, pp. 1380\u20131383. https:\/\/doi.org\/10.1007\/978-0-387-79948-3_1532","DOI":"10.1007\/978-0-387-79948-3_1532"},{"issue":"1","key":"381_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3109\/01677063.2016.1144751","volume":"30","author":"EV Efimova","year":"2016","unstructured":"Efimova EV, Gainetdinov RR, Budygin EA, Sotnikova TD (2016) Dopamine transporter mutant animals: a translational perspective. J Neurogenet 30(1):5\u201315","journal-title":"J Neurogenet"},{"issue":"3","key":"381_CR26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1124\/pr.56.3.1","volume":"56","author":"G Eisenhofer","year":"2004","unstructured":"Eisenhofer G, Kopin IJ, Goldstein DS (2004) Catecholamine metabolism: a contemporary view with implications for physiology and medicine. Pharmacol Rev 56(3):331\u2013349","journal-title":"Pharmacol Rev"},{"issue":"1","key":"381_CR27","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1124\/molpharm.124.000881","volume":"106","author":"A El-Kasaby","year":"2024","unstructured":"El-Kasaby A, Boytsov D, Kasture A, Krumpl G, Hummel T, Freissmuth M, Sandtner W (2024) Allosteric inhibition and pharmacochaperoning of the serotonin transporter by the antidepressant drugs trazodone and nefazodone. Mol Pharmacol 106(1):56\u201370","journal-title":"Mol Pharmacol"},{"issue":"50","key":"381_CR28","doi-asserted-by":"publisher","first-page":"39201","DOI":"10.1074\/jbc.M110.118000","volume":"285","author":"A El-Kasaby","year":"2010","unstructured":"El-Kasaby A, Just H, Malle E, Stolt-Bergner PC, Sitte HH, Freissmuth M, Kudlacek O (2010) Mutations in the carboxyl-terminal SEC24 binding motif of the serotonin transporter impair folding of the transporter*. J Biol Chem 285(50):39201\u201339210","journal-title":"J Biol Chem"},{"issue":"12","key":"381_CR29","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1021\/jm100054f","volume":"53","author":"CG Evans","year":"2010","unstructured":"Evans CG, Chang L, Gestwicki JE (2010) Heat shock protein 70 (Hsp70) as an emerging drug target. J Med Chem 53(12):4585\u20134602","journal-title":"J Med Chem"},{"issue":"17","key":"381_CR30","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1002\/1873-3468.12751","volume":"591","author":"MR Fern\u00e1ndez-Fern\u00e1ndez","year":"2017","unstructured":"Fern\u00e1ndez-Fern\u00e1ndez MR, Gragera M, Ochoa-Ibarrola L, Quintana-Gallardo L, Valpuesta JM (2017) Hsp70\u2014a master regulator in protein degradation. FEBS Lett 591(17):2648\u20132660","journal-title":"FEBS Lett"},{"key":"381_CR104","doi-asserted-by":"crossref","unstructured":"Fleckenstein AE, P\u00f6g\u00fcn S, Carroll FI, Kuhar MJ (1996) Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride]. J Pharmacol Exp Ther 279(1):200\u2013206.","DOI":"10.1016\/S0022-3565(25)20955-7"},{"key":"381_CR31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/164_2017_71","volume":"245","author":"M Freissmuth","year":"2018","unstructured":"Freissmuth M, Stockner T, Sucic S (2018) SLC6 transporter folding diseases and pharmacochaperoning. Handb Exp Pharmacol 245:249\u2013270","journal-title":"Handb Exp Pharmacol"},{"key":"381_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev.pharmtox.43.050802.112309","volume":"43","author":"RR Gainetdinov","year":"2003","unstructured":"Gainetdinov RR, Caron MG (2003) Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 43:261\u2013284","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"5400","key":"381_CR33","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1126\/science.283.5400.397","volume":"283","author":"RR Gainetdinov","year":"1999","unstructured":"Gainetdinov RR, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG (1999) Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283(5400):397\u2013401","journal-title":"Science"},{"key":"381_CR34","first-page":"VS06","volume":"48","author":"E Galiart","year":"2017","unstructured":"Galiart E, Weber P, Datta AN (2017) Infantile dystonia parkinsonism caused by a mutation in SLC6A3: case report of three siblings. Neuropediatrics 48:VS06","journal-title":"Neuropediatrics"},{"issue":"9","key":"381_CR35","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1038\/s41436-019-0451-z","volume":"21","author":"DP Germain","year":"2019","unstructured":"Germain DP, Nicholls K, Giugliani R, Bichet DG, Hughes DA, Barisoni LM, Colvin RB, Jennette JC, Skuban N, Castelli JP et al (2019) Efficacy of the pharmacologic chaperone migalastat in a subset of male patients with the classic phenotype of Fabry disease and migalastat-amenable variants: data from the phase 3 randomized, multicenter, double-blind clinical trial and extension study. Genet Med 21(9):1987\u20131997","journal-title":"Genet Med"},{"issue":"6566","key":"381_CR36","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/379606a0","volume":"379","author":"B Giros","year":"1996","unstructured":"Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379(6566):606\u2013612","journal-title":"Nature"},{"issue":"43","key":"381_CR37","doi-asserted-by":"publisher","first-page":"17095","DOI":"10.1523\/JNEUROSCI.0890-13.2013","volume":"33","author":"JP Golden","year":"2013","unstructured":"Golden JP, DeMaro JA, Knoten A, Hoshi M, Pehek E, Johnson EM, Gereau RW, Jain S (2013) Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons. J Neurosci 33(43):17095\u201317107","journal-title":"J Neurosci"},{"issue":"3","key":"381_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/sj.mp.4000711","volume":"5","author":"F Gr\u00fcnhage","year":"2000","unstructured":"Gr\u00fcnhage F, Schulze TG, M\u00fcller DJ, Lanczik M, Franzek E, Albus M, Borrmann-Hassenbach M, Knapp M, Cichon S, Maier W et al (2000) Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1). Mol Psychiatry 5(3):275\u2013282","journal-title":"Mol Psychiatry"},{"issue":"2","key":"381_CR39","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0022-2836(02)00442-4","volume":"320","author":"R Guerois","year":"2002","unstructured":"Guerois R, Nielsen JE, Serrano L (2002) Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations. J Mol Biol 320(2):369\u2013387","journal-title":"J Mol Biol"},{"issue":"12","key":"381_CR40","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/mp.2013.102","volume":"18","author":"PJ Hamilton","year":"2013","unstructured":"Hamilton PJ, Campbell NG, Sharma S, Erreger K, Herborg Hansen F, Saunders C, Belovich AN, NIH ARRA Autism Sequencing Consortium, Daly MJ, Gibbs RA et al (2013) De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry 18(12):1315\u20131323","journal-title":"Mol Psychiatry"},{"issue":"11","key":"381_CR42","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1097\/00001756-199808030-00026","volume":"9","author":"A Hattori","year":"1998","unstructured":"Hattori A, Luo Y, Umegaki H, Munoz J, Roth GS (1998) Intrastriatal injection of dopamine results in DNA damage and apoptosis in rats. NeuroReport 9(11):2569","journal-title":"NeuroReport"},{"issue":"6","key":"381_CR43","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.mito.2012.09.003","volume":"12","author":"J He","year":"2012","unstructured":"He J, Qi Z, Su Y, He Q, Liu J, Yu L, Al-Attas OS, Hussain T, De Rosas ET, Ji L et al (2012) Pifithrin-\u03bc increases mitochondrial COX biogenesis and MnSOD activity in skeletal muscle of middle-aged mice. Mitochondrion 12(6):630\u2013639","journal-title":"Mitochondrion"},{"issue":"4","key":"381_CR44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/ahg.12378","volume":"84","author":"E Heidari","year":"2020","unstructured":"Heidari E, Razmara E, Hosseinpour S, Tavasoli AR, Garshasbi M (2020) Homozygous in-frame variant of SCL6A3 causes dopamine transporter deficiency syndrome in a consanguineous family. Ann Hum Genet 84(4):315\u2013323","journal-title":"Ann Hum Genet"},{"issue":"15","key":"381_CR46","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1021\/acschemneuro.3c00354","volume":"14","author":"M Hersey","year":"2023","unstructured":"Hersey M, Chen AY, Bartole MK, Anand J, Newman AH, Tanda G (2023) An FSCV study on the effects of targeted typical and atypical DAT inhibition on dopamine dynamics in the nucleus accumbens shell of male and female mice. ACS Chem Neurosci 14(15):2802\u20132810","journal-title":"ACS Chem Neurosci"},{"key":"381_CR47","doi-asserted-by":"publisher","unstructured":"Holleran KM, Rose JH, Fordahl SC, Benton KC, Rohr KE, Gasser PJ, Jones SR (2020) Organic cation transporter 3 and the dopamine transporter differentially regulate catecholamine uptake in the basolateral amygdala and nucleus accumbens. Eur J Neurosci. https:\/\/doi.org\/10.1111\/ejn.14927.","DOI":"10.1111\/ejn.14927"},{"key":"381_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep46280","volume":"7","author":"P Illiano","year":"2017","unstructured":"Illiano P, Bass CE, Fichera L, Mus L, Budygin EA, Sotnikova TD, Leo D, Espinoza S, Gainetdinov RR (2017) Recombinant adeno-associated virus-mediated rescue of function in a mouse model of dopamine transporter deficiency syndrome. Sci Rep 7:46280","journal-title":"Sci Rep"},{"issue":"10","key":"381_CR49","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1046\/j.1460-9568.1999.00764.x","volume":"11","author":"M Jaber","year":"1999","unstructured":"Jaber M, Dumartin B, Sagn\u00e9 C, Haycock JW, Roubert C, Giros B, Bloch B, Caron MG (1999) Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur J Neurosci 11(10):3499\u20133511","journal-title":"Eur J Neurosci"},{"issue":"52","key":"381_CR50","doi-asserted-by":"publisher","first-page":"21030","DOI":"10.1073\/pnas.1315194110","volume":"110","author":"JA Janovick","year":"2013","unstructured":"Janovick JA, Stewart MD, Jacob D, Martin LD, Deng JM, Stewart CA, Wang Y, Cornea A, Chavali L, Lopez S et al (2013) Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapy. Proc Natl Acad Sci USA 110(52):21030\u201321035","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"381_CR51","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/syn.20554","volume":"62","author":"Y Jiang","year":"2008","unstructured":"Jiang Y, Pei L, Li S, Wang M, Liu F (2008) Extracellular dopamine induces the oxidative toxicity of SH-SY5Y cells. Synapse 62(11):797\u2013803","journal-title":"Synapse"},{"issue":"7","key":"381_CR52","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1073\/pnas.95.7.4029","volume":"95","author":"SR Jones","year":"1998","unstructured":"Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 95(7):4029\u20134034","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"381_CR53","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1021\/cr078246a","volume":"108","author":"BI Kanner","year":"2008","unstructured":"Kanner BI, Zomot E (2008) Sodium-coupled neurotransmitter transporters. Chem Rev 108(5):1654\u20131668","journal-title":"Chem Rev"},{"issue":"40","key":"381_CR54","doi-asserted-by":"publisher","first-page":"20876","DOI":"10.1074\/jbc.M116.737551","volume":"291","author":"A Kasture","year":"2016","unstructured":"Kasture A, El-Kasaby A, Sz\u00f6ll\u0151si D, Asjad HMM, Grimm A, Stockner T, Hummel T, Freissmuth M, Sucic S (2016) Functional rescue of a misfolded Drosophila melanogaster dopamine transporter mutant associated with a sleepless phenotype by pharmacological chaperones *\u2666. J Biol Chem 291(40):20876\u201320890","journal-title":"J Biol Chem"},{"key":"381_CR55","doi-asserted-by":"crossref","unstructured":"Kaufman DM (ed.) (2007) Chapter 21\u2014Neurotransmitters and drug abuse. In: Clinical neurology for psychiatrists, sixth edition. W.B. Saunders, pp 511\u2013536","DOI":"10.1016\/B978-141603074-4.10021-9"},{"key":"381_CR56","first-page":"53","volume":"2","author":"N Klepac","year":"2013","unstructured":"Klepac N, Habek M, Adamec I, Baru\u0161i\u0107 AK, Bach I, Margeti\u0107 E, Lu\u0161i\u0107 I (2013) An update on the management of young-onset Parkinson\u2019s disease. Degener Neurol Neuromuscul Dis 2:53\u201362","journal-title":"Degener Neurol Neuromuscul Dis"},{"issue":"1","key":"381_CR57","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S1474-4422(10)70269-6","volume":"10","author":"MA Kurian","year":"2011","unstructured":"Kurian MA, Li Y, Zhen J, Meyer E, Hai N, Christen H-J, Hoffmann GF, Jardine P, von Moers A, Mordekar SR, O\u2019Callaghan F, Wassmer E et al (2011) Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol 10(1):54\u201362","journal-title":"Lancet Neurol"},{"issue":"6","key":"381_CR58","first-page":"1595","volume":"119","author":"MA Kurian","year":"2009","unstructured":"Kurian MA, Zhen J, Cheng S-Y, Li Y, Mordekar SR, Jardine P, Morgan NV, Meyer E, Tee L, Pasha S et al (2009) Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism-dystonia. J Clin Investig 119(6):1595\u20131603","journal-title":"J Clin Investig"},{"issue":"1","key":"381_CR59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10545-017-0079-6","volume":"41","author":"A Kuster","year":"2018","unstructured":"Kuster A, Arnoux J-B, Barth M, Lamireau D, Houcinat N, Goizet C, Doray B, Gobin S, Schiff M, Cano A et al (2018) Diagnostic approach to neurotransmitter monoamine disorders: Experience from clinical, biochemical, and genetic profiles. J Inherit Metab Dis 41(1):129\u2013139","journal-title":"J Inherit Metab Dis"},{"key":"381_CR60","doi-asserted-by":"publisher","first-page":"173334","DOI":"10.1016\/j.pbb.2022.173334","volume":"213","author":"R Lalonde","year":"2022","unstructured":"Lalonde R, Strazielle C (2022) Neurochemical anatomy of dorsal and tonic immobility responses. Pharmacol Biochem Behav 213:173334","journal-title":"Pharmacol Biochem Behav"},{"key":"381_CR61","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.phrs.2014.01.005","volume":"83","author":"NJ Leidenheimer","year":"2014","unstructured":"Leidenheimer NJ, Ryder KG (2014) Pharmacological chaperoning: a primer on mechanism and pharmacology. Pharmacol Res 83:10\u201319","journal-title":"Pharmacol Res"},{"issue":"1","key":"381_CR62","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.molcel.2009.09.023","volume":"36","author":"JI-J Leu","year":"2009","unstructured":"Leu JI-J, Pimkina J, Frank A, Murphy ME, George DL (2009) A small molecule inhibitor of inducible heat shock protein 70. Mol Cell 36(1):15\u201327","journal-title":"Mol Cell"},{"issue":"4","key":"381_CR63","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3109\/15563650.2016.1138226","volume":"54","author":"RPW Litjens","year":"2016","unstructured":"Litjens RPW, Brunt TM (2016) How toxic is ibogaine?. Clin Toxicol 54(4):297\u2013302","journal-title":"Clin Toxicol"},{"key":"381_CR64","doi-asserted-by":"crossref","unstructured":"Liu YB, Tewari A, Salameh J, Arystarkhova E, Hampton TG, Brashear A, Ozelius LJ, Khodakhah K, Sweadner KJ (2015) A dystonia-like movement disorder with brain and spinal neuronal defects is caused by mutation of the mouse laminin \u03b21 subunit, Lamb1. eLife 4:e11102","DOI":"10.7554\/eLife.11102"},{"issue":"15","key":"381_CR65","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1097\/00001756-200110290-00029","volume":"12","author":"Z Liu","year":"2001","unstructured":"Liu Z, Zhang J, Fei J, Guo L (2001) A novel mechanism of dopamine neurotoxicity involving the peripheral extracellular and the plasma membrane dopamine transporter. NeuroReport 12(15):3293","journal-title":"NeuroReport"},{"key":"381_CR66","unstructured":"Martin D, Le JK (2025) Amphetamine. In StatPearls. [Internet]. Treasure Island (FL): StatPearls Publishing. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556103\/"},{"issue":"7","key":"381_CR67","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1177\/0269881116641331","volume":"30","author":"DC Mash","year":"2016","unstructured":"Mash DC, Ameer B, Prou D, Howes JF, Maillet EL (2016) Oral noribogaine shows high brain uptake and anti-withdrawal effects not associated with place preference in rodents. J Psychopharmacol 30(7):688\u2013697","journal-title":"J Psychopharmacol"},{"key":"381_CR68","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.nbd.2014.10.016","volume":"74","author":"ST Masoud","year":"2015","unstructured":"Masoud ST, Vecchio LM, Bergeron Y, Hossain MM, Nguyen LT, Bermejo MK, Kile B, Sotnikova TD, Siesser WB, Gainetdinov RR et al (2015) Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits. Neurobiol Dis 74:66\u201375","journal-title":"Neurobiol Dis"},{"issue":"6","key":"381_CR69","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.neuropharm.2005.08.003","volume":"49","author":"MS Mazei-Robison","year":"2005","unstructured":"Mazei-Robison MS, Couch RS, Shelton RC, Stein MA, Blakely RD (2005) Sequence variation in the human dopamine transporter gene in children with attention deficit hyperactivity disorder. Neuropharmacology 49(6):724\u2013736","journal-title":"Neuropharmacology"},{"issue":"1","key":"381_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-11-34","volume":"11","author":"J Meiser","year":"2013","unstructured":"Meiser J, Weindl D, Hiller K (2013) Complexity of dopamine metabolism. Cell Commun Signal 11(1):34","journal-title":"Cell Commun Signal"},{"key":"381_CR71","first-page":"55523","volume":"123","author":"CJ Miedel","year":"2017","unstructured":"Miedel CJ, Patton JM, Miedel AN, Miedel ES, Levenson JM (2017) Assessment of spontaneous alternation, novel object recognition and limb clasping in transgenic mouse models of amyloid-\u03b2 and tau neuropathology. J Vis Exp: JoVE 123:55523","journal-title":"J Vis Exp: JoVE"},{"issue":"7","key":"381_CR72","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1038\/s41380-020-00859-4","volume":"26","author":"CA Mielnik","year":"2021","unstructured":"Mielnik CA, Binko MA, Chen Y, Funk AJ, Johansson EM, Intson K, Sivananthan N, Islam R, Milenkovic M, Horsfall W et al (2021) Consequences of NMDA receptor deficiency can be rescued in the adult brain. Mol Psychiatry 26(7):2929\u20132942","journal-title":"Mol Psychiatry"},{"issue":"1","key":"381_CR73","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00439-021-02404-x","volume":"141","author":"A Mir","year":"2022","unstructured":"Mir A, Almudhry M, Alghamdi F, Albaradie R, Ibrahim M, Aldurayhim F, Alhedaithy A, Alamr M, Bawazir M, Mohammad S et al (2022) SLC gene mutations and pediatric neurological disorders: Diverse clinical phenotypes in a Saudi Arabian population. Hum Genet 141(1):81\u201399","journal-title":"Hum Genet"},{"issue":"12","key":"381_CR74","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/S0165-6147(00)01575-3","volume":"21","author":"JP Morello","year":"2000","unstructured":"Morello JP, Pet\u00e4j\u00e4-Repo UE, Bichet DG, Bouvier M (2000) Pharmacological chaperones: A new twist on receptor folding. Trends Pharmacol Sci 21(12):466\u2013469","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"381_CR75","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuron.2009.01.033","volume":"62","author":"EV Mosharov","year":"2009","unstructured":"Mosharov EV, Larsen KE, Kanter E, Phillips KA, Wilson K, Schmitz Y, Krantz DE, Kobayashi K, Edwards RH, Sulzer D (2009) Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron 62(2):218\u2013229","journal-title":"Neuron"},{"issue":"Suppl 3","key":"381_CR77","first-page":"S57","volume":"7","author":"MM Nasehi","year":"2020","unstructured":"Nasehi MM, Nikkhah A, Salari M, Soltani P, Shirzadi S (2020) Dopamine transporter deficiency syndrome: a case with hyper- and hypokinetic extremes. Mov Disord Clin Pract 7(Suppl 3):S57\u2013S60","journal-title":"Mov Disord Clin Pract"},{"key":"381_CR105","doi-asserted-by":"crossref","unstructured":"Nath T, Mathis A, Chen AC, Patel A, Bethge M, Mathis MW (2019) Using DeepLabCut for 3D markerless pose estimation across species and behaviors. Nat Protoc 14(7):2152\u20132176","DOI":"10.1038\/s41596-019-0176-0"},{"key":"381_CR78","doi-asserted-by":"crossref","unstructured":"Nepal B, Das S, Reith ME, Kortagere S (2023). Overview of the structure and function of the dopamine transporter and its protein interactions. Front Physiol 14:1150355","DOI":"10.3389\/fphys.2023.1150355"},{"issue":"594","key":"381_CR79","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw1564","volume":"13","author":"J Ng","year":"2021","unstructured":"Ng J, Barral S, De La Fuente Barrigon C, Lignani G, Erdem FA, Wallings R, Privolizzi R, Rossignoli G, Alrashidi H, Heasman S et al (2021) Gene therapy restores dopamine transporter expression and ameliorates pathology in iPSC and mouse models of infantile parkinsonism. Sci Transl Med 13(594):eaaw1564","journal-title":"Sci Transl Med"},{"issue":"4","key":"381_CR80","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/brain\/awu022","volume":"137","author":"J Ng","year":"2014","unstructured":"Ng J, Zhen J, Meyer E, Erreger K, Li Y, Kakar N, Ahmad J, Thiele H, Kubisch C, Rider NL et al (2014) Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood. Brain 137(4):1107\u20131119","journal-title":"Brain"},{"issue":"11","key":"381_CR81","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1523\/JNEUROSCI.17-11-04037.1997","volume":"17","author":"MJ Nirenberg","year":"1997","unstructured":"Nirenberg MJ, Chan J, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM (1997) Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J Neurosci 17(11):4037\u20134044","journal-title":"J Neurosci"},{"issue":"2","key":"381_CR82","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1523\/JNEUROSCI.16-02-00436.1996","volume":"16","author":"MJ Nirenberg","year":"1996","unstructured":"Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16(2):436","journal-title":"J Neurosci"},{"issue":"3","key":"381_CR83","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.neures.2004.12.006","volume":"51","author":"T Ogura","year":"2005","unstructured":"Ogura T, Ogata M, Akita H, Jitsuki S, Akiba L, Noda K, Hoka S, Saji M (2005) Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson\u2019s disease. Neurosci Res 51(3):299\u2013308","journal-title":"Neurosci Res"},{"key":"381_CR84","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.08352","volume":"4","author":"SS Pappas","year":"2015","unstructured":"Pappas SS, Darr K, Holley SM, Cepeda C, Mabrouk OS, Wong J-MT, LeWitt TM, Paudel R, Houlden H, Kennedy RT et al (2015) Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons. eLife 4:e08352","journal-title":"eLife"},{"issue":"8","key":"381_CR85","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1038\/npp.2011.45","volume":"36","author":"JK Pinsonneault","year":"2011","unstructured":"Pinsonneault JK, Han DD, Burdick KE, Kataki M, Bertolino A, Malhotra AK, Gu HH, Sadee W (2011) Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder. Neuropsychopharmacology 36(8):1644\u20131655","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"381_CR86","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.1073\/pnas.0707646105","volume":"105","author":"A Salahpour","year":"2008","unstructured":"Salahpour A, Ramsey AJ, Medvedev IO, Kile B, Sotnikova TD, Holmstrand E, Ghisi V, Nicholls PJ, Wong L, Murphy K et al (2008) Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc Natl Acad Sci USA 105(11):4405\u20134410","journal-title":"Proc Natl Acad Sci USA"},{"key":"381_CR87","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1146\/annurev.biophys.33.110502.140348","volume":"33","author":"CR Sanders","year":"2004","unstructured":"Sanders CR, Myers JK (2004) Disease-related misassembly of membrane proteins. Annu Rev Biophys Biomol Struct 33:25\u201351","journal-title":"Annu Rev Biophys Biomol Struct"},{"issue":"5","key":"381_CR88","doi-asserted-by":"publisher","first-page":"806","DOI":"10.3390\/biom13050806","volume":"13","author":"A Savchenko","year":"2023","unstructured":"Savchenko A, Targa G, Fesenko Z, Leo D, Gainetdinov RR, Sukhanov I (2023) Dopamine transporter deficient rodents: perspectives and limitations for neuroscience. Biomolecules 13(5):806","journal-title":"Biomolecules"},{"issue":"6779","key":"381_CR89","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/35008096","volume":"404","author":"U Schubert","year":"2000","unstructured":"Schubert U, Ant\u00f3n LC, Gibbs J, Norbury CC, Yewdell JW, Bennink JR (2000) Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404(6779):770\u2013774","journal-title":"Nature"},{"key":"381_CR90","first-page":"A226","volume":"81","author":"APR Silva","year":"2023","unstructured":"Silva APR, de Souza J, Valle DA, Zeny MS, Marques IC, Junior R, Spinosa MJ, Auersvald EC, Santos BV (2023) Case report of two brothers with infantile Parkinsonism-dystonia (OMIM #613135). Arquivos de Neuro-Psiquiatria 81:A226","journal-title":"Arquivos de Neuro-Psiquiatria"},{"issue":"8","key":"381_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0030271","volume":"3","author":"TD Sotnikova","year":"2005","unstructured":"Sotnikova TD, Beaulieu J-M, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR (2005) Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. PLoS Biol 3(8):e271","journal-title":"PLoS Biol"},{"key":"381_CR92","doi-asserted-by":"crossref","unstructured":"Sotnikova TD, Caron MG, Gainetdinov RR (2006) DDD mice, a novel acute mouse model of Parkinson\u2019s disease. Neurology 67:S12\u2013S17","DOI":"10.1212\/WNL.67.7_suppl_2.S12"},{"key":"381_CR93","unstructured":"Spaull RVV, Kurian MA (2023) SLC6A3-related dopamine transporter deficiency syndrome. In Adam, MP, Bick, S, Mirzaa GM (Eds.), GeneReviews\u00ae. University of Washington, Seattle. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK442323\/"},{"key":"381_CR94","doi-asserted-by":"crossref","unstructured":"Sutton C, Williams EQ, Homsi H, Beerepoot P, Nazari R, Han D, Ramsey AJ, Mash DC, Olson DE, Blough B et al (2022) Structure-activity relationships of dopamine transporter pharmacological chaperones. Front Cell Neurosci 16:832536","DOI":"10.3389\/fncel.2022.832536"},{"issue":"6","key":"381_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101361","volume":"297","author":"G S\u00f8rensen","year":"2021","unstructured":"S\u00f8rensen G, Rickhag M, Leo D, Lycas MD, Ridderstr\u00f8m PH, Weikop P, Lilja JH, Rifes P, Herborg F, Woldbye D et al (2021) Disruption of the PDZ domain\u2013binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis, and reward motivation. J Biol Chem 297(6):101361","journal-title":"J Biol Chem"},{"issue":"15_supplement","key":"381_CR96","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1212\/WNL.94.15_supplement.1884","volume":"94","author":"B Tehreem","year":"2020","unstructured":"Tehreem B, Kornitzer J (2020) Expanding the phenotypic spectrum of dopamine transporter deficiency syndrome with a novel mutation (1884). Neurology 94(15_supplement):1884","journal-title":"Neurology"},{"issue":"9","key":"381_CR97","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.tips.2013.07.005","volume":"34","author":"RA Vaughan","year":"2013","unstructured":"Vaughan RA, Foster JD (2013) Mechanisms of dopamine transporter regulation in normal and disease states. Trends Pharmacol Sci 34(9):489\u2013496","journal-title":"Trends Pharmacol Sci"},{"key":"381_CR98","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.mcn.2014.05.007","volume":"61","author":"LM Vecchio","year":"2014","unstructured":"Vecchio LM, Bermejo MK, Beerepoot P, Ramsey AJ, Salahpour A (2014) N-terminal tagging of the dopamine transporter impairs protein expression and trafficking in vivo. Mol Cell Neurosci 61:123\u2013132","journal-title":"Mol Cell Neurosci"},{"issue":"4","key":"381_CR99","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/jnc.15432","volume":"158","author":"LM Vecchio","year":"2021","unstructured":"Vecchio LM, Sullivan P, Dunn AR, Bermejo MK, Fu R, Masoud ST, Gregersen E, Urs NM, Nazari R, Jensen PH et al (2021) Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo. J Neurochemistry 158(4):960\u2013979","journal-title":"J Neurochemistry"},{"key":"381_CR100","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1055\/s-0036-1593372","volume":"48","author":"Y Yildiz","year":"2016","unstructured":"Yildiz Y, Pektas E, Tokatli A, Haliloglu G (2016) Hereditary dopamine transporter deficiency syndrome: challenges in diagnosis and treatment. Neuropediatrics 48:49\u201352","journal-title":"Neuropediatrics"},{"issue":"2","key":"381_CR101","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jneumeth.2011.03.001","volume":"202","author":"JT Yorgason","year":"2011","unstructured":"Yorgason JT, Espa\u00f1a RA, Jones SR (2011) Demon voltammetry and analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J Neurosci Methods 202(2):158\u2013164","journal-title":"J Neurosci Methods"},{"key":"381_CR102","doi-asserted-by":"crossref","unstructured":"Young WF (2016) Chapter 16\u2014Endocrine hypertension. In Melmed S, Polonsky KS, Larsen PR, Kronenberg HM (eds) Williams textbook of endocrinology, Thirteenth Edition. Elsevier, pp 556\u2013588","DOI":"10.1016\/B978-0-323-29738-7.00016-2"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00381-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00381-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00381-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:45:25Z","timestamp":1779065125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00381-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":100,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3,13]]}},"alternative-id":["381"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00381-0","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}